TY - JOUR
T1 - D-Lactic acidosis
T2 - Pathologic consequence of saprophytism
AU - Vella, Adrian
AU - Farrugia, Gianrico
PY - 1998
Y1 - 1998
N2 - In this report, we describe a 50-year-old woman with a short bowel who had recurrent episodes of weakness, ataxia, slurred speech, confusion, and nausea. D-Lactic acidosis was diagnosed on the basis of a D-lactate level of 8.2 mmol/L (normal, 0 to 0.25) obtained during an episode of confusion. D- Lactic acidosis is a potentially fatal clinical condition seen in patients with a short small intestine and an intact colon. Excessive production of D- lactate by abnormal bowel flora overwhelms normal metabolism of D-lactate and leads to an accumulation of this enantiomer in the blood. This disorder provides insight into the role of intestinal flora in human metabolism and demonstrates the manner in which altered intestinal flora can produce disease in humans. Increased awareness of D-lactic acidosis is necessary for prompt and appropriate treatment. The pathophysiology and treatment of D-lactic acidosis are reviewed.
AB - In this report, we describe a 50-year-old woman with a short bowel who had recurrent episodes of weakness, ataxia, slurred speech, confusion, and nausea. D-Lactic acidosis was diagnosed on the basis of a D-lactate level of 8.2 mmol/L (normal, 0 to 0.25) obtained during an episode of confusion. D- Lactic acidosis is a potentially fatal clinical condition seen in patients with a short small intestine and an intact colon. Excessive production of D- lactate by abnormal bowel flora overwhelms normal metabolism of D-lactate and leads to an accumulation of this enantiomer in the blood. This disorder provides insight into the role of intestinal flora in human metabolism and demonstrates the manner in which altered intestinal flora can produce disease in humans. Increased awareness of D-lactic acidosis is necessary for prompt and appropriate treatment. The pathophysiology and treatment of D-lactic acidosis are reviewed.
UR - http://www.scopus.com/inward/record.url?scp=0031801065&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031801065&partnerID=8YFLogxK
U2 - 10.1016/S0025-6196(11)63729-4
DO - 10.1016/S0025-6196(11)63729-4
M3 - Review article
C2 - 9581587
AN - SCOPUS:0031801065
SN - 0025-6196
VL - 73
SP - 451
EP - 456
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 5
ER -